Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Treatment of Meniere's Disease With Migraine Medications [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is exploring the use of migraine medications to treat Ménière disease, and recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Irvine | Conditions: Ménière | Phase 4 | Status: RECRUITING